Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

IGM Biosciences: Q3 Earnings Insights

IGM Biosciences (NASDAQ:IGMS) reported its Q3 earnings results on Thursday, November 3, 2022 at 09:05 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
November 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

IGM Biosciences (NASDAQ:IGMS) reported its Q3 earnings results on Thursday, November 3, 2022 at 09:05 AM.

Here’s what investors need to know about the announcement.

Earnings

IGM Biosciences beat estimated earnings by 7.69%, reporting an EPS of $-1.32 versus an estimate of $-1.43.

Revenue was up $331 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.39 which was followed by a 11.31% increase in the share price the next day.

 

To track all earnings releases for IGM Biosciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Black Hills Q2 Earnings

By Benzinga Insights
Today, 2:46 AM
Black Hills (NYSE:BKH) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Black Hills beat estimated earnings by 2.56%, reporting an EPS of $0.4 versus an estimate of $0.39.

BKH